Company intelligence / Profile preview

Regis Technologies

Morton Grove, Illinois, United Statesregistech.com ↗

Ownership: Private
Employees: ~95
Development stage: Commercial

Overview

Regis Technologies does not develop its own clinical candidates but provides process development, analytical services, and cGMP manufacturing of small molecule APIs—including HPAPIs—for pharmaceutical and biotech clients from preclinical through commercialization. The company also manufactures proprietary chromatography products with a focus on chiral separations.

Modalities: Small moleculeHigh potency active pharmaceutical ingredient (HPAPI)Chromatography products (for separation and analysis)Fine organic chemicals
Industry: Contract Manufacturing Organization

Partnerships

Collaborates with pharmaceutical and biotechnology companies globally for contract development and manufacturing services

Beyond the preview

Go deeper on Regis Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regis Technologies.